Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524428 · ClinicalTrials.gov registry record · NA
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
A NA study of Colo-rectal Cancer, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 4
- Study locations
NCT05524428 is a NA study of Colo-rectal Cancer that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 2 participants, below the 2,807-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT05524428, a NA study of Colo-rectal Cancer, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
Conditions Studied
Interventions
- BEHAVIORAL Implementation Science Strategy
Study Locations (4)
Massachusetts
- Codman Square Health Center - Boston
- Brockton Neighborhood Health Center - Brockton
- East Boston Neighborhood Health Center - East Boston
- Duffy Health Center - Hyannis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-03-24 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05524428
The ClinicalTrials.gov registry entry for NCT05524428 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,807-participant average among 11 other Colo-rectal Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colo-rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Implementation Science Strategy is the first listed.
NCT05524428 reports 4 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05524428 about?
NCT05524428 is a clinical study titled "Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study". The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
What is the current status of trial NCT05524428?
This trial is currently recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2023-03-24. Estimated completion is 2026-12.
What conditions does trial NCT05524428 study?
This clinical trial studies the following conditions: Colo-rectal Cancer.
What interventions are being tested in trial NCT05524428?
The interventions under investigation include: Implementation Science Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05524428?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524428 being conducted?
This trial has 4 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colo-rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
RECRUITING · NA
-
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
RECRUITING · Phase 3
-
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
RECRUITING · Phase 2
-
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
-
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RECRUITING · Phase 1
-
Shield Post-Approval Study Protocol
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.